Reconstruction of antibody dynamics and infection histories to evaluate dengue risk

scientific article published in Nature

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1104160729
P356DOI10.1038/S41586-018-0157-4
P932PMC publication ID6064976
P698PubMed publication ID29795354

P50authorSimon CauchemezQ28152057
Justin LesslerQ37366488
Derek CummingsQ60057514
Ananda NisalakQ60059374
Isabel Rodriguez-BarraquerQ62526039
Richard G JarmanQ66732147
Butsaya ThaisomboonsukQ66732175
Leah C KatzelnickQ89811933
P2093author name stringStephen Thomas
Chonticha Klungthong
Timothy Endy
Alan L Rothman
In-Kyu Yoon
Louis Macareo
Henrik Salje
Damon Ellison
Alden Weg
P2860cites workOriginal antigenic sin in dengueQ24570059
The global distribution and burden of dengueQ24628768
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deploymentQ26746185
Dynamic effects of antibody-dependent enhancement on the fitness of virusesQ27472667
Ecological and immunological determinants of dengue epidemicsQ27473480
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in BangkokQ27477511
Spatial and Temporal Clustering of Dengue Virus Transmission in Thai VillagesQ27487319
Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006Q27491001
Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in InfantsQ29620637
Incubation Periods of Mosquito-Borne Viral Infections: A Systematic ReviewQ33332171
Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in NicaraguaQ33337347
A simple model for complex dynamical transitions in epidemicsQ33887980
Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, ThailandQ33959784
Methods to infer transmission risk factors in complex outbreak data.Q33989754
Efficacy of a tetravalent dengue vaccine in children in Latin America.Q34446032
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccineQ34487139
Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysisQ34600668
Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine developmentQ35195545
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypesQ35927343
Measuring Spatial Dependence for Infectious Disease EpidemiologyQ36022615
Revealing the microscale spatial signature of dengue transmission and immunity in an urban populationQ36066463
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison StudyQ36206692
Asymptomatic humans transmit dengue virus to mosquitoesQ36331893
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV InfectionQ36745257
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunityQ37062703
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infectionQ38087545
Dengue diversity across spatial and temporal scales: Local structure and the effect of host population sizeQ38881036
Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, ThailandQ38993646
Estimation of infection and recovery rates for highly polymorphic parasites when detectability is imperfect, using hidden Markov modelsQ39473573
Travelling waves and spatial hierarchies in measles epidemicsQ39587669
Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and controlQ40229200
Dengue in the Early Febrile Phase: Viremia and Antibody ResponsesQ40647864
Humoral immunity and correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis virus in childrenQ42998088
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart StudyQ46977345
Antibody-dependent enhancement of severe dengue disease in humansQ47592202
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin AmericaQ89453187
P433issue7707
P407language of work or nameEnglishQ1860
P304page(s)719-723
P577publication date2018-05-01
P1433published inNatureQ180445
P1476titleReconstruction of antibody dynamics and infection histories to evaluate dengue risk
P478volume557

Reverse relations

cites work (P2860)
Q58606057A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates
Q66679555A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
Q90629672A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques
Q90560585A review of Dengvaxia®: development to deployment
Q99564799A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Q99634545ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
Q94511915An open source tool to infer epidemiological and immunological dynamics from serological data: Serosolver
Q62485190Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?
Q83225458Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
Q56373585Challenges and opportunities in controlling mosquito-borne infections
Q99370861Climate change could shift disease burden from malaria to arboviruses in Africa
Q96165179Combine dengue vaccines to optimize effectiveness
Q66679685Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development
Q93116456Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam
Q91271250Dengue
Q99574588Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
Q83229772Dengue genetic divergence generates within-serotype antigenic variation, but serotypes dominate evolutionary dynamics
Q59352698Dengue: a growing threat requiring vaccine development for disease prevention
Q64099613Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines
Q95268372Dynamics of antibodies to SARS-CoV-2 in a case with SARS-CoV-2 infection
Q64081724Effects of infection history on dengue virus infection and pathogenicity
Q83229071Enteropathogen antibody dynamics and force of infection among children in low-resource settings
Q63246260Global expansion and redistribution of Aedes-borne virus transmission risk with climate change
Q100694566Learning from the past: development of safe and effective COVID-19 vaccines
Q66679636Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand
Q66679750Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus
Q64066509Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates
Q90472263Primary and secondary dengue virus infections elicit similar memory B cell responses but breadth to other serotypes and cross-reactivity to Zika virus is higher in secondary dengue
Q99731978Protective and enhancing interactions among dengue viruses 1-4 and Zika virus
Q92859173Recent advances in understanding dengue
Q99588194Reemergence of dengue virus in Bangladesh: Current fatality and the required knowledge
Q58102330Risk of Dengue in Travelers: Implications for Dengue Vaccination
Q92622870Risk of Zika microcephaly correlates with features of maternal antibodies
Q101226405Risk of dengue virus infection according to serostatus in individuals from dengue endemic areas of Mexico
Q90205634Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease
Q90109621Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia
Q91967484The 'lifecycle' of human beings: a call to explore vector-borne diseases from an ecosystem perspective
Q98386109The role of IgG Fc receptors in antibody-dependent enhancement
Q91732033Thermal biology of mosquito-borne disease
Q91173745Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas
Q92735295Using cluster analysis to reconstruct dengue exposure patterns from cross-sectional serological studies in Singapore
Q66679530West Nile Virus and Usutu Virus Co-Circulation in Europe: Epidemiology and Implications
Q66680074West Nile virus infection in individuals with pre-existing Usutu virus immunity, northern Italy, 2018
Q92441397Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in Dengue-Naive and Dengue-Experienced Pregnant Women and Possible Implication for Cross-Reactivity and Cross-Protection

Search more.